UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000017217
Receipt number R000019971
Scientific Title An open-label extension study following the RIN-1 study to investigate the efficacy of rituximab against a relapse of neuromyelitis optica
Date of disclosure of the study information 2015/04/21
Last modified on 2019/03/29 16:20:01

No. Disposal Last modified on Item of update
1 Insert 2015/04/21 18:24:46
2 Update 2015/10/21 10:26:05 Organization
Organization
Email1
3 Update 2016/03/18 10:09:07 Organization
4 Update 2016/10/21 09:28:27 Name of primary person or sponsor
Institute
Organization
Organization
Category of Funding Organization
5 Update 2018/12/19 11:56:02 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2018/12/19 12:23:15 Email
Email
Email
Email1
7 Update 2019/03/28 13:20:08 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of secondary funder(s)
Name of secondary funder(s)
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/03/28 13:22:42 Recruitment status
Date of IRB
9 Update 2019/03/28 13:40:03 Number of participants that the trial has enrolled
10 Update 2019/03/28 13:41:28 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2019/03/29 16:20:01 Recruitment status